This study aimed to implement a toxigenic culture as an optional third diagnostic step for glutamate dehydrogenase (GDH)-positive and toxin A/B-negative diarrheal stool samples into a diagnostic algorithm for Clostridioides (Clostridium) difficile infection (CDI), and to characterise C. difficile isolates for epidemiological purposes. During the 5-month study, 481 diarrhoeal stool samples from three Slovak hospitals were investigated and 66 non-duplicated GDH-positive stool samples were found. Of them, 36 were also toxin A/B-positive. Twenty-three GDH-positive and toxin A/B-negative stool samples were shown subsequently to be positive following toxigenic culture (TC). Molecular characterisation of C. difficile isolates showed the predominance of PCR ribotype (RT) 001 (n = 37, 56.1%) and the occurrence of RT 176 (n = 3, 4.5%). C. difficile RT 001 isolates clustered to eight clonal complexes (CCs) using multiple-locus variable-number tandem repeats analysis (MLVA). Interestingly, one third of RT 001 isolates clustering in these CCs were cultured from toxin A/B-negative stool samples. Our observations highlight the need of use multiple step diagnostic algorithm in CDI diagnosis in order to detect all CDI cases and to avoid the spread of C. difficile in healthcare settings.

Department of Medical Microbiology 2nd Faculty of Medicine Charles University and Motol University Hospital 5 Uvalu 84 150 06 Prague 5 Czech Republic

Department of Microbiology Medirex Group Kosice Slovakia

Zobrazit více v PubMed

FEMS Microbiol Lett. 1999 Jun 15;175(2):261-6 PubMed

J Hosp Infect. 2001 Jul;48(3):233-7 PubMed

J Clin Microbiol. 2007 Mar;45(3):1024-8 PubMed

J Clin Microbiol. 2007 Nov;45(11):3601-5 PubMed

J Med Microbiol. 2008 Nov;57(Pt 11):1377-82 PubMed

Clin Microbiol Infect. 2008 Nov;14(11):1057-64 PubMed

Clin Microbiol Infect. 2009 Dec;15(12):1080-6 PubMed

Clin Microbiol Rev. 2010 Jul;23(3):529-49 PubMed

J Med Microbiol. 2012 Jan;61(Pt 1):49-56 PubMed

Infect Genet Evol. 2012 Oct;12(7):1577-85 PubMed

Nat Genet. 2013 Jan;45(1):109-13 PubMed

Folia Microbiol (Praha). 2014 Nov;59(6):523-6 PubMed

Lancet Infect Dis. 2014 Dec;14(12):1208-19 PubMed

PLoS One. 2015 Feb 13;10(2):e0118150 PubMed

Eur J Clin Microbiol Infect Dis. 2015 Aug;34(8):1701-8 PubMed

Euro Surveill. 2015;20(38):null PubMed

Anaerobe. 2016 Aug;40:35-40 PubMed

Anaerobe. 2016 Aug;40:95-9 PubMed

Clin Microbiol Infect. 2016 Aug;22 Suppl 4:S63-81 PubMed

Euro Surveill. 2016 Jul 21;21(29): PubMed

Euro Surveill. 2016 Jul 21;21(29): PubMed

Euro Surveill. 2016 Jul 21;21(29): PubMed

Int J Med Microbiol. 2016 Nov;306(7):479-485 PubMed

J Med Microbiol. 2016 Oct;65(10):1158-1163 PubMed

Anaerobe. 2016 Dec;42:142-144 PubMed

Lancet Infect Dis. 2017 Apr;17(4):411-421 PubMed

Clin Infect Dis. 2017 May 1;64(9):1163-1170 PubMed

J Microbiol Immunol Infect. 2018 Jun;51(3):344-351 PubMed

Anaerobe. 2017 Dec;48:179-183 PubMed

Gut Pathog. 2017 Aug 14;9:45 PubMed

Clin Microbiol Infect. 2018 May;24(5):463-468 PubMed

Nature. 2018 Jan 18;553(7688):291-294 PubMed

Clin Microbiol Infect. 2018 Oct;24(10):1051-1054 PubMed

The emergence of Clostridium difficile ribotypes 027 and 176 with a predominance of the Clostridium difficile ribotype 001 recognized in Slovakia following the European standardized Clostridium difficile infection surveillance of 2016